Yes, clinical phenotypes can provide valuable prognostic information. Factors such as tumor grade, stage, and the presence of certain biomarkers can indicate the likely course of the disease. For instance, high-grade tumors are generally more aggressive and have a poorer prognosis compared to low-grade tumors. Similarly, cancers detected at an early stage typically have a better prognosis than those diagnosed at a later stage.
